Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|April 8, 2020
Hirayama Disease: A Case of an Albanian Woman Clinically Stabilized Without SurgeryAnnibale Antonioni, Mattia Fonderico, Enrico Granieri
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2021
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis surveyEmilio Portaccio, Mattia Fonderico, Bernhard Hemmer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 1, 2020
Experience with rituximab therapy in a real-life sample of multiple sclerosis patientsAngelo Bellinvia, Elio Prestipino, Emilio Portaccio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 2, 2022
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapiesAngelo Bellinvia, Maria Grazia Aprea, Emilio Portaccio, et al.
Frontiers in Neurology|January 9, 2019
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis PatientsMassimiliano Castellazzi, Daniela Ligi, Elena Contaldi, et al.
Brain Sciences|November 27, 2021
Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and PrognosisMattia Fonderico, Emilio Portaccio, Lorenzo Razzolini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 20, 2018
Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk areaMarta Caniglia-Tenaglia, Susanna Guttmann, Chiara Monaldini, et al.
Frontiers in Neurology|September 8, 2017
Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation TherapyMattia Fonderico, Michele Laudisi, Nico Golfrè Andreasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 25, 2020
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical seriesMattia Fonderico, Tiziana Biagioli, Luisa Lanzilao, et al.
Frontiers in Neurology|April 5, 2021
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple SclerosisEmilio Portaccio, Angelo Bellinvia, Elio Prestipino, et al.
Pageof 3